$ALDR Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ALDER BIOPHARMACEUTICALS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of all insider trading transactions in ALDER BIOPHARMACEUTICALS INC. Get notifications about new insider transactions in ALDER BIOPHARMACEUTICALS INC for free.

Page:   < prev 1 2 3 4 5 next >

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Nov 09 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOOption ExerciseM1.6510,00016,500108,181
Nov 09 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOSellS25.1610,000251,605114,768124.8 K to 114.8 K (-8.01 %)
Nov 09 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOBuyM1.6510,00016,500124,768114.8 K to 124.8 K (+8.71 %)
Nov 03 2016ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...Option ExerciseM1.653,0004,95024,363
Nov 03 2016ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...SellS24.884009,9500400 to 0 (-100.00 %)
Nov 03 2016ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...SellS24.262,60063,0824003 K to 400 (-86.67 %)
Nov 03 2016ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...BuyM1.653,0004,9503,0000 to 3 K
Oct 19 2016ALDRALDER BIOPHARMACEU ...Litton Mark JamesChief Business Offi ...SellS27.502,00055,00026,00028 K to 26 K (-7.14 %)
Oct 19 2016ALDRALDER BIOPHARMACEU ...Litton Mark JamesChief Business Offi ...SellS27.502,00055,00526,00028 K to 26 K (-7.14 %)
Oct 19 2016ALDRALDER BIOPHARMACEU ...Litton Mark JamesChief Business Offi ...SellS27.502,00054,99326,00028 K to 26 K (-7.14 %)
Oct 11 2016ALDRALDER BIOPHARMACEU ...Benedict LarryEVP and PAOOption ExerciseA30.2030,000906,00030,000
Oct 11 2016ALDRALDER BIOPHARMACEU ...Benedict LarryEVP and PAOGrantA8.502,00017,00030,24728.2 K to 30.2 K (+7.08 %)
Oct 07 2016ALDRALDER BIOPHARMACEU ...Sandoval ElisabethChief Commercial Of ...Option ExerciseA31.47225,0007,080,750225,000
Oct 05 2016ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...Option ExerciseM1.653,0004,95027,363
Oct 05 2016ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...SellS31.6270222,1990702 to 0 (-100.00 %)
Oct 05 2016ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...SellS30.992,29871,2167023 K to 702 (-76.60 %)
Oct 05 2016ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...BuyM1.653,0004,9503,0000 to 3 K
Oct 05 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOOption ExerciseM1.278,18110,3490
Oct 05 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOSellS31.552,70085,189114,768117.5 K to 114.8 K (-2.30 %)
Oct 05 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOSellS30.955,481169,622117,468122.9 K to 117.5 K (-4.46 %)
Oct 05 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOBuyM1.278,18110,349122,949114.8 K to 122.9 K (+7.13 %)
Oct 05 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...Option ExerciseM1.6510,00016,50013,636
Oct 05 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...SellS31.516,249196,888242,200248.4 K to 242.2 K (-2.52 %)
Oct 05 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...SellS31.003,751116,263248,449252.2 K to 248.4 K (-1.49 %)
Oct 05 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...BuyM1.6510,00016,500252,200242.2 K to 252.2 K (+4.13 %)
Sep 06 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...Option ExerciseM1.6510,00016,50023,636
Sep 06 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...SellS32.4910,000324,949242,200252.2 K to 242.2 K (-3.97 %)
Sep 06 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...BuyM1.6510,00016,500252,200242.2 K to 252.2 K (+4.13 %)
Sep 06 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOOption ExerciseM1.2710,00012,6508,181
Sep 06 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOSellS32.4810,000324,820114,768124.8 K to 114.8 K (-8.01 %)
Sep 06 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOBuyM1.2710,00012,650124,768114.8 K to 124.8 K (+8.71 %)
Sep 06 2016ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...Option ExerciseM1.653,0004,95030,363
Sep 06 2016ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...SellS33.101003,3100100 to 0 (-100.00 %)
Sep 06 2016ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...SellS32.472,90094,1731003 K to 100 (-96.67 %)
Sep 06 2016ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...BuyM1.653,0004,9503,0000 to 3 K
Aug 17 2016ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...Option ExerciseM1.653,0004,95033,363
Aug 17 2016ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...SellS31.173,00093,51203 K to 0 (-100.00 %)
Aug 17 2016ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...BuyM1.653,0004,9503,0000 to 3 K
Aug 03 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOOption ExerciseM1.2710,00012,65018,181
Aug 03 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOSellS32.6916523114,768114.8 K to 114.8 K (-0.01 %)
Aug 03 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOSellS31.684,816152,570114,784119.6 K to 114.8 K (-4.03 %)
Aug 03 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOSellS30.655,168158,420119,600124.8 K to 119.6 K (-4.14 %)
Aug 03 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOBuyM1.2710,00012,650124,768114.8 K to 124.8 K (+8.71 %)
Aug 03 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...Option ExerciseM1.6510,00016,50033,636
Aug 03 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...SellS32.54321,041242,200242.2 K to 242.2 K (-0.01 %)
Aug 03 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...BuyS31.753,574113,484242,232238.7 K to 242.2 K (+1.50 %)
Aug 03 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...SellS30.886,394197,423245,806252.2 K to 245.8 K (-2.54 %)
Aug 03 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...BuyM1.6510,00016,500252,200242.2 K to 252.2 K (+4.13 %)
Jul 28 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...Option ExerciseM1.659,18715,15943,636
Jul 28 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...Option ExerciseM1.658131,34152,823
Jul 28 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...SellS30.159,187277,023242,200251.4 K to 242.2 K (-3.65 %)
Jul 28 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...BuyM1.659,18715,159251,387242.2 K to 251.4 K (+3.79 %)
Jul 28 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...SellS30.0081324,392242,200243 K to 242.2 K (-0.33 %)
Jul 28 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...BuyM1.658131,341243,013242.2 K to 243 K (+0.34 %)
Jul 27 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOOption ExerciseM1.2710,00012,65028,181
Jul 27 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOSellS28.0810,000280,805114,768124.8 K to 114.8 K (-8.01 %)
Jul 27 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOBuyM1.2710,00012,650124,768114.8 K to 124.8 K (+8.71 %)
Jul 18 2016ALDRALDER BIOPHARMACEU ...Whitaker Timothy MChief Medical Offic ...Option ExerciseA25.56225,0005,751,000225,000
Jul 14 2016ALDRALDER BIOPHARMACEU ...Litton Mark JamesChief Business Offi ...Option ExerciseM0.3925,0009,6250
Jul 14 2016ALDRALDER BIOPHARMACEU ...Litton Mark JamesChief Business Offi ...BuyM0.3925,0009,62599,56774.6 K to 99.6 K (+33.53 %)
Jun 07 2016ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...Option ExerciseM1.2716,09020,3540
Jun 07 2016ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...SellS31.831,00031,82701,000 to 0 (-100.00 %)
Jun 07 2016ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...SellS31.003,805117,9401,0004.8 K to 1,000 (-79.19 %)
Jun 07 2016ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...SellS29.7911,285336,1674,80516.1 K to 4.8 K (-70.14 %)
Jun 07 2016ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...BuyM1.2716,09020,35416,0900 to 16.1 K
Jun 03 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOOption ExerciseM1.2710,00012,65038,181
Jun 03 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOSellS30.261,96559,460114,768116.7 K to 114.8 K (-1.68 %)
Jun 03 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOSellS29.518,035237,084116,733124.8 K to 116.7 K (-6.44 %)
Jun 03 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOBuyM1.2710,00012,650124,768114.8 K to 124.8 K (+8.71 %)
Jun 03 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...Option ExerciseM1.6510,00016,50053,636
Jun 03 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...SellS30.0210,000300,216242,200252.2 K to 242.2 K (-3.97 %)
Jun 03 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...BuyM1.6510,00016,500252,200242.2 K to 252.2 K (+4.13 %)
Jun 02 2016ALDRALDER BIOPHARMACEU ...SIEGALL CLAY BDirectorOption ExerciseA29.2615,000438,90015,000
Jun 02 2016ALDRALDER BIOPHARMACEU ...Preston HeatherDirectorOption ExerciseA29.2615,000438,90015,000
Jun 02 2016ALDRALDER BIOPHARMACEU ...PAKIANATHAN DEEPIKADirectorOption ExerciseA29.2615,000438,90015,000
Jun 02 2016ALDRALDER BIOPHARMACEU ...Montgomery Alan BruceDirectorOption ExerciseA29.2615,000438,90015,000
Jun 02 2016ALDRALDER BIOPHARMACEU ...DOW STEPHEN MDirectorOption ExerciseA29.2615,000438,90015,000
Jun 02 2016ALDRALDER BIOPHARMACEU ...Cleveland Paul BDirectorOption ExerciseA29.2615,000438,90015,000
Jun 02 2016ALDRALDER BIOPHARMACEU ...Carter Paul RutherfordDirectorOption ExerciseA29.2615,000438,90015,000
Jun 01 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...Option ExerciseM1.659,09115,00063,636
Jun 01 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...Option ExerciseM1.2724,50831,0030
Jun 01 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...Option ExerciseM1.276,4018,09724,508
Jun 01 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...SellS30.0433,5991,009,284242,200275.8 K to 242.2 K (-12.18 %)
Jun 01 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...BuyM1.659,09115,000275,799266.7 K to 275.8 K (+3.41 %)
Jun 01 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...BuyM1.2724,50831,003266,708242.2 K to 266.7 K (+10.12 %)
Jun 01 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...SellS30.056,401192,335242,200248.6 K to 242.2 K (-2.57 %)
Jun 01 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...BuyM1.276,4018,097248,601242.2 K to 248.6 K (+2.64 %)
Jun 01 2016ALDRALDER BIOPHARMACEU ...Litton Mark JamesChief Business Offi ...Option ExerciseM0.3919,7207,59225,000
Jun 01 2016ALDRALDER BIOPHARMACEU ...Litton Mark JamesChief Business Offi ...Option ExerciseM0.395,2802,03344,720
Jun 01 2016ALDRALDER BIOPHARMACEU ...Litton Mark JamesChief Business Offi ...SellS30.0519,720592,56674,56794.3 K to 74.6 K (-20.91 %)
Jun 01 2016ALDRALDER BIOPHARMACEU ...Litton Mark JamesChief Business Offi ...BuyM0.3919,7207,59294,28774.6 K to 94.3 K (+26.45 %)
Jun 01 2016ALDRALDER BIOPHARMACEU ...Litton Mark JamesChief Business Offi ...SellS30.065,280158,69374,56779.8 K to 74.6 K (-6.61 %)
Jun 01 2016ALDRALDER BIOPHARMACEU ...Litton Mark JamesChief Business Offi ...BuyM0.395,2802,03379,84774.6 K to 79.8 K (+7.08 %)
May 24 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOOption ExerciseM1.274,0175,08248,181
May 24 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOOption ExerciseM1.272,9973,79152,198
May 24 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOOption ExerciseM1.272,9863,77755,195
May 24 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOSellS28.034,017112,588112,947117 K to 112.9 K (-3.43 %)
May 24 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOBuyM1.274,0175,082116,964112.9 K to 117 K (+3.56 %)
May 24 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOSellS28.012,99783,952112,947115.9 K to 112.9 K (-2.58 %)
May 24 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOBuyM1.272,9973,791115,944112.9 K to 115.9 K (+2.65 %)
May 24 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOSellS28.012,98683,635112,947115.9 K to 112.9 K (-2.58 %)
May 24 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOBuyM1.272,9863,777115,933112.9 K to 115.9 K (+2.64 %)
Mar 07 2016ALDRALDER BIOPHARMACEU ...Bucher James BSr. VP & General Co ...Option ExerciseA20.1795,0001,916,15095,000
Apr 18 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOOption ExerciseM1.274,5145,71058,181
Apr 18 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOOption ExerciseM1.275,4866,94062,695
Apr 18 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOOption ExerciseM0.398,5383,2870
Apr 18 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOOption ExerciseM0.3911,4624,4138,538
Apr 18 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOSellS28.084,514126,742112,947117.5 K to 112.9 K (-3.84 %)
Apr 18 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOBuyM1.274,5145,710117,461112.9 K to 117.5 K (+4.00 %)
Apr 18 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOSellS28.1114,024394,150112,947127 K to 112.9 K (-11.05 %)
Apr 18 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOBuyM1.275,4866,940126,971121.5 K to 127 K (+4.52 %)
Apr 18 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOBuyM0.398,5383,287121,485112.9 K to 121.5 K (+7.56 %)
Apr 18 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOSellS28.0111,462321,075112,947124.4 K to 112.9 K (-9.21 %)
Apr 18 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOBuyM0.3911,4624,413124,409112.9 K to 124.4 K (+10.15 %)
Feb 02 2016ALDRALDER BIOPHARMACEU ...Hassler RandalSVP, Pharmaceutical ...Option ExerciseA24.1875,0001,813,50075,000
Feb 02 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...Option ExerciseA24.18100,0002,418,000100,000
Feb 02 2016ALDRALDER BIOPHARMACEU ...Litton Mark JamesChief Business Offi ...Option ExerciseA24.1850,0001,209,00050,000
Feb 02 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOOption ExerciseA24.18236,5005,718,570236,500
Feb 02 2016ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...Option ExerciseA24.18100,0002,418,000100,000
Feb 02 2016ALDRALDER BIOPHARMACEU ...Benedict LarrySr. VP FinanceOption ExerciseA24.1840,000967,20040,000
Feb 02 2016ALDRALDER BIOPHARMACEU ...Benedict LarrySr. VP FinanceGrantA8.502,00017,00028,24726.2 K to 28.2 K (+7.62 %)
Jan 06 2016ALDRALDER BIOPHARMACEU ...Litton Mark JamesChief Business Offi ...Option ExerciseM0.3925,0009,62550,000
Jan 06 2016ALDRALDER BIOPHARMACEU ...Litton Mark JamesChief Business Offi ...SellS31.867,709245,57373,71881.4 K to 73.7 K (-9.47 %)
Jan 06 2016ALDRALDER BIOPHARMACEU ...Litton Mark JamesChief Business Offi ...SellS31.1917,291539,37981,42798.7 K to 81.4 K (-17.52 %)
Jan 06 2016ALDRALDER BIOPHARMACEU ...Litton Mark JamesChief Business Offi ...BuyM0.3925,0009,62598,71873.7 K to 98.7 K (+33.91 %)
Jan 06 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...Option ExerciseM1.2710,00012,65030,909
Jan 06 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...SellS32.013,500112,040241,726245.2 K to 241.7 K (-1.43 %)
Jan 06 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...SellS31.096,500202,097245,226251.7 K to 245.2 K (-2.58 %)
Jan 06 2016ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...BuyM1.2710,00012,650251,726241.7 K to 251.7 K (+4.14 %)
Jan 06 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOOption ExerciseM0.3910,0003,85020,000
Jan 06 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOSellS31.952,02064,546111,579113.6 K to 111.6 K (-1.78 %)
Jan 06 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOSellS31.357,980250,201113,599121.6 K to 113.6 K (-6.56 %)
Jan 06 2016ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOBuyM0.3910,0003,850121,579111.6 K to 121.6 K (+8.96 %)
Dec 03 2015ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...Option ExerciseM0.394,2721,6450
Dec 03 2015ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...SellS37.244,272159,10404.3 K to 0 (-100.00 %)
Dec 03 2015ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...BuyM0.394,2721,6454,2720 to 4.3 K
Dec 03 2015ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...Option ExerciseM0.394,5501,7520
Dec 03 2015ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...SellS37.244,550169,452241,726246.3 K to 241.7 K (-1.85 %)
Dec 03 2015ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...BuyM0.394,5501,752246,276241.7 K to 246.3 K (+1.88 %)
Dec 03 2015ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOOption ExerciseM0.3910,0003,85030,000
Dec 03 2015ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOSellS37.2410,000372,431111,579121.6 K to 111.6 K (-8.23 %)
Dec 03 2015ALDRALDER BIOPHARMACEU ...Schatzman Randall CPresident and CEOBuyM0.3910,0003,850121,579111.6 K to 121.6 K (+8.96 %)
Dec 02 2015ALDRALDER BIOPHARMACEU ...DOW STEPHEN MDirectorSellS37.11883,266088 to 0 (-100.00 %)
Nov 04 2015ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...Option ExerciseM0.394,5451,7504,550
Nov 04 2015ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...SellS34.432,34580,729241,265243.6 K to 241.3 K (-0.96 %)
Nov 04 2015ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...SellS33.3280026,658243,610244.4 K to 243.6 K (-0.33 %)
Nov 04 2015ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...SellS32.681,40045,750244,410245.8 K to 244.4 K (-0.57 %)
Nov 04 2015ALDRALDER BIOPHARMACEU ...Latham John AChief Scientific Of ...BuyM0.394,5451,750245,810241.3 K to 245.8 K (+1.88 %)
Nov 04 2015ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...Option ExerciseM0.393,9001,5024,272
Nov 04 2015ALDRALDER BIOPHARMACEU ...Smith Jeffrey T LSr. VP Translationa ...SellS34.571,40048,39301.4 K to 0 (-100.00 %)

Page:   < prev 1 2 3 4 5 next >

Contact us | Follow us on Twitter